Cell and gene therapies, which involve the transfer of genetic material or cells into a patient for treatment, have been on ...

Viatris shares fell to a 52-week low after the drug company said issues related to a India facility are expected to hurt 2025 total revenue by about $500 million. The stock was recently down 14% to $9 ...

The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...

ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs ...

The rule would prevent many cereal and yogurt products from making nutrition claims and allow nuts, oils and certain seafood ...

In January, the U.S. Sentencing Commission announced proposed amendments to federal drug sentencing guidelines, including ...

Leadership in statistical programming is about more than managing deliverables—it’s about inspiring teams and exceeding ...

New EU Clinical Trial Regulations simplify international trials while offering the means to counter drug shortages for trials ...

India's drug regulator aims to implement various reforms, including streamlining export clearances for unapproved drugs and ...

Follow President Donald Trump's executive order, the Department of Health and Human Services issued new guidance that ...

India's drug regulator plans to streamline export clearances and simplify manufacturing licensing to reduce workforce burden.

Forge consensus on a modern regulatory framework. The Trump administration could encourage the development of a ...